Citing enrollment challenges, Bristol Myers and 2seventy scrap Abecma trial in first-line myeloma
25th September 2024 Uncategorised 0 Citing enrollment challenges, Bristol Myers and 2seventy scrap Abecma trial in first-line myeloma
aliu
Wed, 09/25/2024 – 10:23
More: Citing enrollment challenges, Bristol Myers and 2seventy scrap Abecma trial in first-line myeloma
Source: fierce